Newsletter
Digoxin vs Bisoprolol for AFib, Risk of Second Cancer After a First Cancer, Review of GERD and more

JAMA Editor’s Summary

Digoxin vs Bisoprolol for AFib, Risk of Second Cancer After a First Cancer, Review of GERD and more

Editor's Summary by Howard Bauchner, MD, Editor in Chief of JAMA, the Journal of the American Medical Association, for the
December 22, 2020

Digoxin vs Bisoprolol for AFib, Risk of Second Cancer After a First Cancer, Review of GERD and more

Editor’s Summary by Howard Bauchner, MD, Editor in Chief of JAMA, the Journal of the American Medical Association, for the December 22/29, 2020 issue

You may also like

The Latest Health Podcasts. Delivered to Your Inbox.

Join Our Newsletter

Proudly supported by:

cover
Four Authors Untangle When Dad Has Dementia Virtual Q&A on the changes and challenges a dementia diagnosis.